Sex-specific associations between sleep apnoea and lung cancer risk in patients with COPD: a nationwide prospective cohort study
The Lancet Regional Health - Europe,
Journal Year:
2025,
Volume and Issue:
52, P. 101269 - 101269
Published: March 21, 2025
Language: Английский
Intersection between lung cancer and neuroscience: opportunities and challenges
Cancer Letters,
Journal Year:
2025,
Volume and Issue:
unknown, P. 217701 - 217701
Published: April 1, 2025
Language: Английский
Identification of Overlapping Genetic Signatures Between Obstructive Sleep Apnea and Lung Cancer: Moving Beyond “One Drug, One Disease” Paradigm of Pharmaceutical Innovation
OMICS A Journal of Integrative Biology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 8, 2025
Traditional
paradigms
of
pharmaceutical
innovation
have
long
relied
on
the
"one
drug,
one
disease"
premise.
However,
a
network
mindset
in
unpacking
disease
mechanisms
can
be
fruitful
to
move
toward
polydisease"
paradigm
drug
discovery
and
development.
A
case
point
is
obstructive
sleep
apnea
(OSA)
lung
cancer,
which
are
two
prevalent
respiratory
disorders
that
share
common
risk
factors
may
potentially
exhibit
overlapping
molecular
mechanisms.
The
putative
mechanistic
linkages
between
OSA
cancer
remain
underexplored;
however,
this
study
offers
new
evidence
genetic
signatures
with
an
in-silico
approach.
Bioinformatics
analysis
publicly
available
datasets
(GSE135917
GSE268175)
identified
123
upregulated
13
downregulated
genes
3175
2272
cancer.
total
four
(C1GALT1,
TMEM106B,
ZNF117,
ZNF486)
were
significantly
both
disorders,
highlighting
shared
Pathway
cell
enrichment
indicated
mucin
type
O-glycan
biosynthesis
pathway
endothelial
cells
strongly
associated
these
genes,
lending
support
for
their
potential
roles
diseases.
Moreover,
hsa-miR-34a-5p,
hsa-let-7g-5p,
hsa-miR-19a-3p
found
genes.
Validation
using
GEPIA2
tool
confirmed
consistent
expression
patterns
Machine
learning
highlighted
TMEM106B
as
most
significant
biomarker
candidate
distinguishing
from
controls.
In
summary,
supports
overarching
concept
human
diseases
pathways
specific
example
While
findings
call
further
research
validation,
they
invite
rethinking
current
beyond
concept.
Language: Английский
Obstructive Sleep Apnea is an Independent Risk Factor for Pulmonary Nodules
Jianxiong Lai,
No information about this author
Shenyu Wen,
No information about this author
Jiahe Wang
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 21, 2025
Abstract
Background
Although
previous
studies
have
suggested
a
potential
connection
between
OSA
and
lung
cancer,
the
relationship
pulmonary
nodules
remains
inadequately
explored.
Objective:
This
study
aimed
to
clarify
nodules.
Methods
We
conducted
cross-sectional
on
303
patients
suspected
of
OSA,
using
polysomnography
(PSG)
assess
severity
low-dose
chest
computed
tomography
(LDCT)
for
nodule
screening.
Logistic
regression
assessed
association
Results
A
higher
proportion
had
concurrent
compared
non-OSA
(P
=
0.008).
In
univariate
logistic
regression,
was
significantly
associated
with
(OR
2.506,
95%
CI:
1.278–4.914,
P
0.008),
in
multivariate
analysis,
remained
independently
(adjusted
OR
2.240,
1.064–4.718,
0.034).
also
prevalence
ground-glass
0.006).
Univariate
showed
5.627,
1.320–23.985,
0.020),
5.326,
1.171–24.227,
0.030).
The
analysis
that
moderate-to-severe
2.4-fold
increased
risk
mild
2-fold
patients(P
<
0.05).
Conclusion
is
an
independent
factor
nodules,
its
risk,
highlighting
need
early
screening
patients.
Language: Английский
Mapping the comorbidome: A novel analysis of the associations between obstructive sleep apnea and its comorbidities in Colombia
Johan Rincón-Hernández,
No information about this author
Eduardo Tuta-Quintero,
No information about this author
Kamil Faizal-Gómez
No information about this author
et al.
Science Progress,
Journal Year:
2025,
Volume and Issue:
108(2)
Published: April 1, 2025
Introduction
Obstructive
sleep
apnea
(OSA)
is
linked
to
a
complex
network
of
comorbidities,
including
cardiovascular,
metabolic,
neurological,
and
oncological
diseases.
The
comorbidome
visually
maps
disease
associations,
highlighting
the
interconnected
comorbidities
OSA,
whose
incidence
severity
are
strongly
correlated.
Methods
A
retrospective
cohort
study
was
conducted
between
2005
2020
identify
most
frequently
associated
with
OSA
through
comprehensive
comorbidity
map.
prevalence
each
calculated
as
percentage,
detailed
analysis
performed
examine
relationship
these
OSA.
This
graphic
represents
all
significant
associations
where
size
bubble
proportional
within
cohort,
proximity
center
reflects
strength
association.
Results
total
3043
patients
diagnosed
were
included,
whom
51.1%
(1154/3043)
had
severe
29.2%
(889/3043)
moderate
19.7%
(600/3043)
mild
average
age
57.6
years
(SD
±
15.32),
65.6%
(1995/3043)
men.
Among
hypertension
present
in
48.0%
(288/600),
53.0%
(470/889),
58.5%
(909/1554).
Renal
failure
(OR:
9.39;
95%
CI:
3.7–23.84),
cardiovascular
7.73;
3.92–15.21),
dementia
6.98;
2.85–17.11),
hemiplegia/stroke
sequelae
6.90;
2.02–23.51),
smoking
5.54;
2.74–11.21),
diabetes
4.34;
2.02–9.35)
Hemiplegia/stroke
10.11;
3.8–26.89),
9.77;
6.18–15.46),
chronic
pulmonary
7.48;
4.76–11.77),
6.80;95%
3.37–13.71)
Dementia
10.59;
6.41–17.5),
leukemia
lymphoma
7.49;
2–28.1),
7.24;
5.33–9.83),
hemiplegia
or
stroke
6.33;
3.3–12.16),
renal
6.10;
3.97–9.36)
Conclusion
prevalent
hypertension,
smoking,
disease,
higher
Additionally,
association
observed
certain
mortality,
particularly
conditions
such
dementia.
Malignant
neoplastic
diseases
related
Language: Английский
Wearable sleep apnea detection device based on PVDF novel sensor
Meihua Song,
No information about this author
Songguo Yu,
No information about this author
Zhong Mo
No information about this author
et al.
Published: Aug. 23, 2024
Language: Английский
Clinical significance of the combined systemic immune-inflammatory index and prognostic nutritional index in predicting the prognosis of patients with extensive-stage small-cell lung cancer receiving immune-combination chemotherapy
Bingbing Wang,
No information about this author
Jingdan Zhang,
No information about this author
Yusheng Shi
No information about this author
et al.
BMC Cancer,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Dec. 24, 2024
The
therapeutic
efficacy
and
prognosis
of
various
tumors
can
be
assessed
using
the
systemic
immune-inflammatory
index
(SII)
prognostic
nutritional
(PNI).
Despite
their
potential,
no
studies
have
investigated
value
combined
SII-PNI
score
for
outcomes
in
patients
with
extensive
small
cell
lung
cancer
(ES-SCLC)
treated
chemotherapy
immune
checkpoint
inhibitors
(ICIs).
Our
study
retrospectively
examined
213
ES-SCLC
ICIs
across
two
institutions.
were
divided
into
three
groups
based
on
scores.
Cox
regression
analysis
was
employed
to
identify
independent
factors.
A
nomogram
constructed
these
With
1000
repeated
samples,
bootstrap
method
used
validate
model
internally.
model's
performance
calibration
curves,
receiver
operating
characteristic
(ROC)
decision
curve
(DCA).
Before
after
(ICIs),
SII
significantly
higher
PD
group
compared
PR
(both
p
<
0.05).
In
meantime,
PNI
considerably
lower
than
0.01).
Kaplan-Meier
curves
demonstrated
that
a
low
had
prolonged
progression-free
survival
(PFS)
overall
(OS)
those
high
(all
Multivariate
showed
PS
=
1,
bone
metastasis,
brain
1,2
four
treatment
cycles
risk
factors
shorter
OS
included
model.
ROC
C-index,
DCA
confirm
scores-based
nomograms
strong
predictive
accuracy
OS.
There
significant
correlation
between
pre-
post-treatment
effect
ES-SCLC.
is
useful
indicator
receiving
Language: Английский